Thank you, Rajiv. I will first review our Q3 fiscal '24 results followed by guidance for Q4 fiscal '24 and the implied full year fiscal year '24 guidance. Results in Q3 '24 came in above the high end of our range across all guided metrics. ACV billings in Q3 were $289 million, above the guided range of $265 million to $275 million, representing year-over-year growth of 20%. Revenue in Q3 was $525 million, higher than the guided range of $510 million to $520 million, representing a year-over-year growth rate of 17%. ARR at the end of Q3 was $1.82 billion, representing year-over-year growth of 24%. In Q3, we continue to see modestly elongated average sales cycles compared to historical levels. Average contract duration in Q3 was three years higher than Q2. Non-GAAP gross margin in Q3 was 86.5%, higher than our guided range of approximately 85%. Non-GAAP operating margin in Q3 was 14% higher than our guided range of 7.5% to 8.5%, largely due to: one, lower operating expenses as a result of higher-than-expected nonrecurring payments related to one of our partnership agreements and timing of hiring; and two, higher revenue and higher gross margin. Non-GAAP net income in Q3 was $85 million or fully diluted EPS of $0.28 per share based on fully diluted weighted average shares outstanding of approximately 302 million shares. DSOs based on revenue and ending accounts receivable were 39 days in Q3. Free cash flow in Q3 was $78 million, representing a free cash flow margin of 15%. We ended Q3 with cash, cash equivalents and short-term investments of $1.651 billion, up slightly from $1.644 billion at the end of Q2. We continued repurchasing shares in Q3 under the share repurchase program previously authorized by our Board of Directors. We have repurchased about $106 million worth of shares year-to-date through Q3 '24. As a reminder, our sustainable generation of free cash flow enabled us to transition to net share settlement to pay for employees' tax liability on RSU vesting starting in Q2 and going forward from our previous method of cell to cover. We used $58 million of our cash in Q3 and $53 million in Q2 for a total of over $111 million of cash year-to-date for this purpose. More information on the mechanics of net share settlement and its impact can be found in the Appendix section of our earnings presentation found on our Investor Relations website. This along with our share repurchase program will help us continue to manage dilution. Moving to Q4 '24. Our guidance for Q4 is as follows: ACV billings of $295 million to $305 million, revenue of $530 million to $540 million, non-GAAP gross margin of 85% to 86% and non-GAAP operating margin of 9% to 10% and fully diluted shares outstanding of approximately 302 million shares. The updated guidance for full year fiscal year '24 is as follows: ACV billings of $1.12 billion to $1.13 billion, representing a year-over-year growth of 18% at the midpoint of the range, revenue of $2.13 billion to $2.14 billion, representing a year-over-year growth of 15% at the midpoint, non-GAAP gross margin of approximately 86%, non-GAAP operating margin of approximately 15% and free cash flow of $520 million to $540 million, representing a free cash flow margin of 25% at the midpoint. I will now provide some commentary regarding our updated fiscal year '24 guidance, specifically the following four points: first, we are seeing continued and significant new and expansion opportunities for our solutions. However, we continue to see a higher mix of larger deals in our pipeline which is driving greater variability in our new and expansion business. The number of opportunities greater than $1 million in ACV in our pipeline has grown at higher than 30% for each of the last 3 quarters compared to the corresponding quarters last year. Relatedly, the dollar amount of pipeline from opportunities greater than $1 million in ACV has grown at well over 50% and for each of the last three quarters compared to the corresponding quarters last year. These larger opportunities often involve strategic decisions and C-suite approvals, causing them to take longer to close and to have greater variability in timing, outcome and deal structure. And as we mentioned previously, we have continued to see a modest elongation of average sales cycles relative to historical levels. Our fiscal year '24 new and expansion ACV and ARR performance year-to-date have been affected by these dynamics and have been below our initial expectations at the beginning of the fiscal year. We expect these dynamics to continue in Q4. As an example, for the eight figure ACV transaction in Q3 that Rajiv mentioned, we expect the billings and cash collection to be in Q4, while the associated subscription revenue is expected to be recognized over multiple years starting in fiscal year '25. Additionally, it is worth noting that this transaction was approximately two years in the making, taking longer to close than our prior expectations, but came in with a longer contract duration and a higher total contract value than expected. We anticipate similar variability in deal structures and longer sales cycles for some of the larger opportunities in our pipeline. Second, the guidance assumes that our renewals business will continue to perform well in Q4. Third, the full year guidance continues to assume that average contract duration would be flat to slightly lower compared to fiscal year '23, as renewals continue to grow as a percentage of our billing. Fourth, the updated full year free cash flow guidance includes the benefit of the eight figure ACV transaction, which was booked in Q3. In addition, the full year free cash flow guidance also assumes the impact of certain nonrecurring benefits over the course of the year, including approximately $40 million of operating expenses, of which we expect to receive approximately $30 million of non-recurring cash payments related to one of our partnership agreements. In closing, we are pleased that our Q3 performance exceeded guidance across all metrics and to continue to make significant progress aligned with our stated philosophy of sustainable, profitable growth. With that, operator, please open the line for questions.